AI-powered drug discovery platform focusing on developing drugs for major medical challenges.

Tool: Verge Genomics
Description: AI-powered drug discovery platform focusing on developing drugs for major medical challenges.
Summary: Verge Genomics leverages an all-in-human, AI-powered drug discovery platform, CONVERGE®, to develop drugs for diseases with no effective treatments, such as ALS, Parkinson's Disease, and Frontotemporal Dementia. Utilizing one of the world's largest proprietary multi-omics databases from human tissue, the platform employs machine learning to map diseases' complex causes and rapidly develop proprietary drug candidates.
Category: Drug Discovery
Tags: Genomics, Precision Medicine
Use Cases: Developing VRG50635, a small molecule inhibitor for ALS, using the CONVERGE® platform.; Mapping complex causes of Parkinson's Disease to develop effective treatments.
Platform: Web
Vendor: Verge Genomics
Target Users: Enterprise
Pricing: not for sale
Regulatory: not a medical device
Meta: Verge Genomics uses an AI-powered platform for drug discovery, focusing on diseases like ALS and Parkinson's, leveraging human genomics and machine learning.
Content: Verge Genomics [![Verge Genomics](https://images.squarespace-cdn.com/content/v1/5e06abec6d6c7a1fb0a3354b/8f1fc7c2-94a2-4f4c-abc2-480e6fecc38c/vg-pl-b.png)](https://www.vergegenomics.com/) [Leadership](https://www.vergegenomics.com/about) [Approach](https://www.vergegenomics.com/approach) [Pipeline](https://www.vergegenomics.com/pipeline) [Partnerships](https://www.vergegenomics.com/partnerships) [News](https://www.vergegenomics.com/news) [Careers](https://www.vergegenomics.com/join-us) [![Verge Genomics](https://images.squarespace-cdn.com/content/v1/5e06abec6d6c7a1fb0a3354b/8f1fc7c2-94a2-4f4c-abc2-480e6fecc38c/vg-pl-b.png)](https://www.vergegenomics.com/) [Leadership](https://www.vergegenomics.com/about) [Approach](https://www.vergegenomics.com/approach) [Pipeline](https://www.vergegenomics.com/pipeline) [Partnerships](https://www.vergegenomics.com/partnerships) [News](https://www.vergegenomics.com/news) [Careers](https://www.vergegenomics.com/join-us) Scroll # We are building the next enduring biotechnology company of the digital age. * * * Verge has pioneered the industry's most advanced all-in-human, artificial intelligence powered drug discovery platform to unlock new drugs at scale for the biggest medical challenges of our time. * * * [See our approach](https://www.vergegenomics.com/approach) ![Hero image.jpg](https://images.squarespace-cdn.com/content/v1/5e06abec6d6c7a1fb0a3354b/1657935881081-FEGRXFSZRKW3AG86MXW6/Hero+image.jpg?format=2500w) ## **Our mission is to develop better drugs, faster using technology.** Verge was born from the convergence of multiple technological forces, including human genomics, machine learning, biological engineering, and translational medicine, that are enabling us to decipher biology. Instead of using animal or cell models, we have built one of the world's largest proprietary multi-omics databases directly from human tissue. We use machine learning to map the complex causes of disease and develop those insights into proprietary drug candidates on our internal biology and chemistry platforms. ### **In order to succeed in humans, we start in humans.** [EXPLORE OUR APPROACH →](https://www.vergegenomics.com/approach) ![Home-our-mission-image.jpg](https://images.squarespace-cdn.com/content/v1/5e06abec6d6c7a1fb0a3354b/1657936387209-85GNJ0OIGKIBZO4EWKQU/Home-our-mission-image.jpg?format=2500w) ## We are developing drugs to treat the biggest medical challenges of our generation. Our first drug VRG50635, a small molecule inhibitor of PIKfyve, has entered the clinic for amyotrophic lateral sclerosis (ALS). It was discovered by CONVERGE®, Verge’s all-in-human, AI-powered platform, moving from research to clinic in just four years. We are working on a dozen breakthrough opportunities on Parkinson's Disease, Frontotemporal Dementia, and other devastating diseases with no effective treatments to date. [See our pipeline →](https://www.vergegenomics.com/pipeline) ![Home-developing-drugs-image.jpg](https://images.squarespace-

Verge Genomics uses an AI-powered platform for drug discovery, focusing on diseases like ALS and Parkinson's, leveraging human genomics and machine learning.

Verge Genomics

Verge Genomics leverages an all-in-human, AI-powered drug discovery platform, CONVERGE®, to develop drugs for diseases with no effective treatments, such as ALS, Parkinson's Disease, and Frontotemporal Dementia. Utilizing one of the world's largest proprietary multi-omics databases from human tissue, the platform employs machine learning to map diseases' complex causes and rapidly develop proprietary drug candidates.

Verge Genomics

Categories

Description

Summary

Use Cases

Platforms

Regulatory Status

API Available

Added to Directory

Target Customer

Contact